The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Completed
CT.gov ID
NCT00226265
Collaborator
(none)
50
1
104
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    50 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    The Short Form-36: Pre-vs. Post-Surgical Administration in Cardiac Surgery Patients
    Actual Study Start Date :
    Jan 1, 1999
    Actual Primary Completion Date :
    Dec 1, 2006
    Actual Study Completion Date :
    Sep 1, 2007

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 100 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • Cardiac surgery patients who are between the ages of 18 and 100

      • Are English speaking

      • Able to give consent

      • Undergoing cardiac surgery including (but not limited to):

      • Aortic valve replacement (AVR)

      • Mitral valve replacement (MVR)

      • Tricuspid valve replacement (TVR)

      • Coronary artery bypass graft (CABG).

      Exclusion Criteria:
      • Non-cardiac surgery patients

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 The New York Presbyterian Hospital-Weill Medical Center New York New York United States 10021

      Sponsors and Collaborators

      • Weill Medical College of Cornell University

      Investigators

      • Principal Investigator: Mary E Charlson, MD, Weill Medical College of Cornell University

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Mary E. Charlson, MD, Principal Investigator, Weill Medical College of Cornell University
      ClinicalTrials.gov Identifier:
      NCT00226265
      Other Study ID Numbers:
      • 1203-069
      First Posted:
      Sep 26, 2005
      Last Update Posted:
      Feb 23, 2017
      Last Verified:
      Feb 1, 2017
      Individual Participant Data (IPD) Sharing Statement:
      No
      Plan to Share IPD:
      No
      Keywords provided by Mary E. Charlson, MD, Principal Investigator, Weill Medical College of Cornell University
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Feb 23, 2017